Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs

Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs

<p>Abstract</p> <p>Background</p> <p>This study aimed to investigate existing trialling activity relating to three antipsychotic drugs from the WHO List of Essential Medicines (chlorpromazine, fluphenazine decanoate, haloperidol), link existing trials to existing Cochra...

Full description

Bibliographic Details
Main Authors:	Barbui Corrado, Purgato Marianna, Adams Clive E
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	International Journal of Mental Health Systems
Online Access:	http://www.ijmhs.com/content/5/1/25

Similar Items

Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity?
by: Purgato Marianna, et al.
Published: (2012-07-01)

Forty-five years of schizophrenia trials in Italy: a survey
by: Purgato Marianna, et al.
Published: (2012-04-01)

The Cochrane Schizophrenia Group
by: Clive Adams, et al.
Published: (1999-06-01)

Is it SAFe to use WSJF for prioritisation in financial software development? : A case study of prioritisation needs at a Swedish bank
by: Dahlström, Gustav, et al.
Published: (2019)

Cochrane method for evaluating the efficacy of drugs, national contribution to international Cochrane collaboration
by: D. L. Varganova, et al.
Published: (2019-12-01)

Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics.
by: Fabrizio Starace, et al.
Published: (2018-01-01)

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
by: Giulia Turrini, et al.
Published: (2017-08-01)

The African continent needs to prioritise planetary health
by: Iyiola Olatunji Oladunjoye, et al.
Published: (2021-11-01)

Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials
by: McGuire Hugh, et al.
Published: (2002-04-01)

Cochrane systematic review protocols
by: Jayant N Palaskar
Published: (2015-01-01)

Prioritising children and adolescents in the tuberculosis response of the WHO European Region
by: Matthias I. Gröschel, et al.
Published: (2019-03-01)

Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials
by: Borrill Jo, et al.
Published: (2005-10-01)

Geneva calling: WHO resolution on mental disorders
by: Barbui Corrado, et al.
Published: (2012-06-01)

Cochrane Corner: Evaluation of the Cochrane systematic review “Antiplatelet agents for chronic kidney disease”
by: Daniel Caldeira, et al.
Published: (2013-11-01)

Prioritising CAP Intervention Needs: An Improved Cumulative Voting Approach
by: Roberto Cagliero, et al.
Published: (2021-04-01)

The clinical role of therapeutic drug monitoring of antiretrovirals : a Cochrane systematic review
by: Kredo, Tamara
Published: (2014)

From meta‐analysis to Cochrane reviews
by: Nicole Ebner, et al.
Published: (2018-06-01)

Heterogeneity in Cochrane and non-Cochrane meta-analyses in orthodontics
by: Fleming, P.S, et al.
Published: (2018)

Statistical multiplicity in systematic reviews of anaesthesia interventions: a quantification and comparison between Cochrane and non-Cochrane reviews.
by: Georgina Imberger, et al.
Published: (2011-01-01)

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
by: Emanuel Raschi, et al.
Published: (2013-01-01)

Cochrane Corner: Withdrawal of antihypertensive drugs in older people
by: Filipa Reis, et al.
Published: (2021-05-01)

Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
by: Hanna Bergman, et al.
Published: (2017-08-01)

Cochrane highlights
by: Rachel Riera, et al.

Biologics for rheumatoid arthritis: an overview of Cochrane reviews
by: Jasvinder A. Singh, et al.

Using Machine Intelligence to Prioritise Code Review Requests
by: Saini, Nishrith
Published: (2020)

Cochrane and its prospects in Bosnia and Herzegovina: Relying on Cochrane Croatia
by: Mersiha Mahmić-Kaknjo, et al.
Published: (2015-05-01)

Distribution of country of origin in studies used in Cochrane Reviews.
by: Robert F Wolff, et al.
Published: (2011-01-01)

The quality of Cochrane systematic reviews of acupuncture: an overview
by: Zhaochen Ji, et al.
Published: (2020-10-01)

Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)
by: Chavdar S Pavlov, et al.
Published: (2019-08-01)

Cochrane Eyes and Vision: systematic reviews on myopia
by: Jennifer Evans
Published: (2019-05-01)

Reporting of the Role of the Expert Searcher in Cochrane Reviews
by: Margaret Sampson, et al.
Published: (2006-12-01)

Reporting of the Role of the Expert Searcher in Cochrane Reviews
by: Li Zhang, et al.
Published: (2006-12-01)

Reporting of the role of the expert searcher in Cochrane Reviews
by: Zhang, Li, et al.
Published: (2007)

Neuraminidase inhibitors: the story behind the Cochrane review
by: Doshi, Peter
Published: (2009)

A systematic review of atypical antipsychotic drugs in schizophrenia
by: A-.M. Bagnall, et al.
Published: (2003-01-01)

Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook
by: Ognjen Barcot, et al.
Published: (2019-08-01)

Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis.
by: Michela Nosè, et al.
Published: (2017-01-01)

Information retrieval for the Cochrane systematic reviews: the case of breast cancer surgery
by: Gaetana Cognetti, et al.
Published: (2015-03-01)

A new approach to psychiatric drug approval in Europe.
by: Corrado Barbui, et al.
Published: (2013-10-01)

Antipsychotic Drugs Rechallenge in Multi-antipsychotic Drug Induced Atypical Neuroleptic Malignant Syndrome: A Case of Cotard’s Syndrome
by: Helin Yılmaz, et al.
Published: (2017-03-01)